SECTRA (SECT) Q4 23/24 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 23/24 earnings summary
31 Jan, 2026Executive summary
Net sales increased 26.1% to SEK 2,963.6 million, with all business areas showing growth and strong progress in transitioning to a cloud-based, as-a-service model, especially in Imaging IT and Secure Communications.
Cloud recurring revenue grew 55.9% year-over-year to SEK 400 million, with total recurring revenue at SEK 1.7 billion.
Order bookings rose 34.3% to SEK 6,223.5 million, and customer satisfaction remains high, with churn at 0.4% and multiple industry awards.
Operating profit rose 13.6% to SEK 517.8 million, with a margin of 17.5%.
The Board proposes a SEK 1.10 per share distribution via share redemption program.
Financial highlights
Revenues increased by 26.1% year-over-year, reaching SEK 2,963.6 million.
Operating profit rose 13.6% to SEK 517.8 million, with a margin of 17.5%.
Earnings per share increased to SEK 2.22, up 14% year-over-year and 190% over five years.
Cash flow from operations was SEK 326.3 million, and cash balance at period end was SEK 804.6 million.
Cloud recurring revenues up 55.9% year-over-year; all business segments showed sales growth.
Outlook and guidance
The transition to service and cloud-based sales is expected to temporarily dampen growth, but recurring revenue is becoming the majority of sales and long-term prospects remain strong.
Secure Communications and Imaging IT positioned for continued high demand due to market trends and external factors.
Full benefits of the business model transition are expected in a few years, especially as more customers outside North America adopt cloud services.
Genomics IT module has strong interest, with reference sales expected before broader market adoption.
Latest events from SECTRA
- Cloud recurring revenue surged 58% and operating profit rose 21%, led by Imaging IT growth.SECT
Q3 25/266 Mar 2026 - Q1 sales up 24%, operating profit up 44%, with strong recurring and cloud revenue growth.SECT
Q1 24/2522 Jan 2026 - Record order intake and recurring revenue growth offset by lower profit during cloud transition.SECT
Q2 24/2511 Jan 2026 - Sales up 13%, cloud recurring revenue up 44%, and profit boosted by a patent settlement.SECT
Q3 24/2521 Dec 2025 - Cloud and recurring revenue growth drive profit, but upfront costs pressure margins.SECT
Q2 25/2612 Dec 2025 - SaaS, AI, and integrated diagnostics drive global growth and leadership in medical IT.SECT
CMD 20251 Dec 2025 - Record order intake and recurring revenue growth drive profitability and cash flow.SECT
Q4 24/2511 Nov 2025 - Order bookings and recurring revenue surged, driven by SaaS and US/Canada growth.SECT
Q1 25/264 Sep 2025